Stay updated on Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page.

Latest updates to the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page
- Check6 days agoChange DetectedRevision v3.4.3 was added and Revision v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check41 days agoChange DetectedAdded a site-wide funding notice to the page. Introduced a new revision entry (v3.4.1) in the record history, and removed the previous revision (v3.4.0).SummaryDifference0.7%

- Check49 days agoChange DetectedAdded a glossary display and color-coded highlights to indicate additions and deletions. Removed the No FEAR Act data entry and updated the revision label to v3.4.0.SummaryDifference0.9%

- Check63 days agoChange DetectedRevision v3.3.4 was added to the study record history and Revision v3.3.3 was removed; this affects only the history metadata.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter/site-wide updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 references. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page.